109 related articles for article (PubMed ID: 20834107)
21. Antiviral prophylaxis for chemotherapy-induced reactivation of chronic hepatitis B virus infection.
Kohrt HE; Ouyang DL; Keeffe EB
Clin Liver Dis; 2007 Nov; 11(4):965-91, x. PubMed ID: 17981237
[TBL] [Abstract][Full Text] [Related]
22. Treatment of hepatitis B with lamivudine and tenofovir in HIV/HBV-coinfected patients: factors associated with response.
Jain MK; Comanor L; White C; Kipnis P; Elkin C; Leung K; Ocampo A; Attar N; Keiser P; Lee WM
J Viral Hepat; 2007 Mar; 14(3):176-82. PubMed ID: 17305883
[TBL] [Abstract][Full Text] [Related]
23. Molecular analysis of an HBsAg-negative hepatitis B virus mutant selected in a tenofovir-treated HIV-hepatitis B virus co-infected patient.
Amini-Bavil-Olyaee S; Sheldon J; Lutz T; Trautwein C; Tacke F
AIDS; 2009 Jan; 23(2):268-72. PubMed ID: 19098499
[TBL] [Abstract][Full Text] [Related]
24. Tenofovir for treatment of hepatitis B virus reactivation in patients with chronic GVHD.
Hilgendorf I; Loebermann M; Borchert K; Junghanss C; Freund M; Schmitt M
Bone Marrow Transplant; 2011 Sep; 46(9):1274-5. PubMed ID: 21151183
[No Abstract] [Full Text] [Related]
25. Proper antiviral therapy for hepatitis B virus-associated acute-on-chronic liver failure.
Liu T; Zhang C; Wang Y
Hepatology; 2011 Aug; 54(2):747-8. PubMed ID: 21360719
[No Abstract] [Full Text] [Related]
26. The role of tenofovir in preventing and treating hepatitis B virus (HBV) reactivation in immunosuppressed patients. A real life experience from a tertiary center.
Koskinas JS; Deutsch M; Adamidi S; Skondra M; Tampaki M; Alexopoulou A; Manolakopoulos S; Pectasides D
Eur J Intern Med; 2014 Oct; 25(8):768-71. PubMed ID: 25037900
[TBL] [Abstract][Full Text] [Related]
27. Reactivation of Occult Hepatitis B Virus Infection 27 Months after the End of Chemotherapy Including Rituximab for Malignant Lymphoma.
Muraishi J; Shibata M; Honma Y; Hiura M; Abe S; Harada M
Intern Med; 2017; 56(15):1967-1971. PubMed ID: 28768965
[TBL] [Abstract][Full Text] [Related]
28. [A case of the usage of entecavir to prevent hepatitis B virus reactivation during chemotherapy in breast cancer patient].
Muraoka T; Taira N; Shien T; Doihara H; Takaki A; Miyoshi S
Gan To Kagaku Ryoho; 2011 Nov; 38(11):1861-4. PubMed ID: 22083198
[TBL] [Abstract][Full Text] [Related]
29. Fatal hepatitis B reactivation treated with entecavir in an isolated anti-HBs positive lymphoma patient: a case report and literature review.
Ferreira R; Carvalheiro J; Torres J; Fernandes A; Giestas S; Mendes S; Agostinho C; Campos MJ
Saudi J Gastroenterol; 2012; 18(4):277-81. PubMed ID: 22824772
[TBL] [Abstract][Full Text] [Related]
30. Use of entecavir in hepatitis B virus reactivation of a patient with non-Hodgkin's lymphoma.
Gozdas HT; Arpaci E
World J Gastroenterol; 2015 Sep; 21(35):10251-2. PubMed ID: 26401092
[TBL] [Abstract][Full Text] [Related]
31. Effect of nucleoside and nucleotide analogues on renal function in patients with chronic hepatitis B virus monoinfection.
Mallet V; Schwarzinger M; Vallet-Pichard A; Fontaine H; Corouge M; Sogni P; Pol S
Clin Gastroenterol Hepatol; 2015 Jun; 13(6):1181-8.e1. PubMed ID: 25460550
[TBL] [Abstract][Full Text] [Related]
32. [A case of drug-induced liver injury caused by entecavir for treatment of hepatitis B virus reactivation during RCHOP in a patient with non-Hodgkin lymphoma].
Kondo M; Kitada N; Kobayashi M; Morita S; Yoshioka M; Tsuji T; Mori A; Okamoto T; Watari M
Gan To Kagaku Ryoho; 2009 Jul; 36(7):1199-201. PubMed ID: 19620818
[TBL] [Abstract][Full Text] [Related]
33. Fatal reactivation of occult hepatitis B virus infection after rituximab and chemotherapy in lymphoma: necessity of antiviral prophylaxis.
Zhang B; Wang J; Xu W; Wang L; Ni W
Onkologie; 2010; 33(10):537-9. PubMed ID: 20926902
[TBL] [Abstract][Full Text] [Related]
34. Similar risk of renal events among patients treated with tenofovir or entecavir for chronic hepatitis B.
Gish RG; Clark MD; Kane SD; Shaw RE; Mangahas MF; Baqai S
Clin Gastroenterol Hepatol; 2012 Aug; 10(8):941-6; quiz e68. PubMed ID: 22507876
[TBL] [Abstract][Full Text] [Related]
35. Hepatitis B reactivation in patient with non-Hodgkin's lymphoma receiving rituximab-based chemotherapy: need for education and attention.
Yang JD; Girotra M; Vaid A; Duarte-Rojo A
J Ark Med Soc; 2013 Nov; 110(6):110-2. PubMed ID: 24367885
[TBL] [Abstract][Full Text] [Related]
36. Hepatitis B virus reactivation in a primary central nervous system lymphoma patient following intrathecal rituximab treatment.
Kim MG; Park SY; Kim EJ; Kim YM; Kim HY; Lee YK; Zang DY; Kim HJ
Acta Haematol; 2011; 125(3):121-4. PubMed ID: 21150178
[TBL] [Abstract][Full Text] [Related]
37. [Viral hepatitis B in a patient with follicular lymphoma treated with biological therapy].
Holub M; Kořínková M; Chalupa P
Klin Mikrobiol Infekc Lek; 2011 Feb; 17(1):30-2. PubMed ID: 21452121
[TBL] [Abstract][Full Text] [Related]
38. [Impending liver failure after chemoimmunotherapy-induced reactivation of hepatitis B - successful treatment with entecavir].
Lock G; Helmich F; Bertram M
Dtsch Med Wochenschr; 2012 Jun; 137(23):1248-50. PubMed ID: 22644491
[TBL] [Abstract][Full Text] [Related]
39. Immunomodulatory effects of tenofovir disoproxil fumarate and entecavir in treating HBV infection.
Yu X; Long J; Xie Y; Zhang J; Su Z
J Hepatol; 2024 Mar; 80(3):e123-e125. PubMed ID: 37598940
[No Abstract] [Full Text] [Related]
40. Editorial: tenofovir disoproxil fumarate vs entecavir in patients with chronic hepatitis B and renal impairment-still an open issue.
Lee SW; Kim SU
Aliment Pharmacol Ther; 2020 Sep; 52(5):889-890. PubMed ID: 32852818
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]